Artesunate-induced severe autoimmune hemolytic anemia in complicated malaria

9Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Autoimmune hemolytic anemia (AIHA) is a very rare cause of anemia in a case of malaria and drug-induced AIHA is even rarer. A 50-year old patient with a history of fever for 8 days was diagnosed with a case of complicated malaria with mixed infection having initial parasite index of 45%. He showed good response on initial therapy with artesunate (parasite count reduced to <1%) but his haemoglobin (Hb) continued to drop from 12 g% to 4.9 g% over a course of 11 days. Direct coombs test was positive with reduced haptoglobin and increased lactate dehydrogenase suggesting AIHA. The patient was put on steroids and transfused with saline washed O-negative blood. He gradually recovered over 8 weeks with Hb level rising up to 12 g%. This is a rare case of AIHA following treatment of severe malaria with parenteral artesunate suggesting of the drug immune-related mechanism.

Cite

CITATION STYLE

APA

Singh, S., Singh, S., Tentu, A., Kumar, A., Shahbabu, B., Singh, V., & Singh, N. (2018). Artesunate-induced severe autoimmune hemolytic anemia in complicated malaria. Indian Journal of Critical Care Medicine, 22(10), 753–756. https://doi.org/10.4103/ijccm.IJCCM_298_18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free